Challenger Wealth Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$612K Sell
6,501
-436
-6% -$41.6K 0.45% 37
2026
Q2
$587K Sell
6,937
-30
-0.4% -$2.42K 0.43% 40
2026
Q1
$493K Sell
6,967
-401
-5% -$30K 0.39% 44
2025
Q4
$582K Buy
7,368
+35
+0.5% +$2.77K 0.44% 37
2025
Q3
$604K Buy
7,333
+113
+2% +$8.89K 0.47% 37
2025
Q2
$581K Sell
7,220
-443
-6% -$34.2K 0.4% 42
2025
Q1
$615K Buy
7,663
+36
+0.5% +$2.99K 0.49% 42
2024
Q4
$625K Buy
+7,627
New +$635K 0.54% 42

Other funds holding MET

Challenger Wealth Management's MET Position: Q3 2026 in Review

Challenger Wealth Management reduced its MetLife (MET) stake by 6.3% in Q3 2026, selling an estimated $41.6K and leaving 6,501 shares worth $612K. The position accounts for 0.45% of the portfolio, ranked #37.

Challenger Wealth Management first reported a position in MET in Q4 2024 and has held it in 8 quarters since. The position peaked at $625K in Q4 2024. 1,516 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Challenger Wealth Management held 6,501 shares of MetLife worth $612K as of Q3 2026.
  • Challenger Wealth Management sold 436 MetLife shares in Q3 2026, an estimated $41.6K.
  • MetLife made up 0.45% of Challenger Wealth Management's portfolio in Q3 2026, its #37 holding.
  • Challenger Wealth Management first reported a position in MetLife in Q4 2024 and has held it in 8 quarters since.
  • Challenger Wealth Management's MetLife position peaked at $625K in Q4 2024.
  • 1,516 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Challenger Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.